微博
加入微博一起分享新鲜事
登录
|
注册
140
Advances in Studies of Chiglitazar Sodium, a Novel PPAR Pan-Agonist, for the Treatment of Type 2 Diabetes Mellitus https://journal.hep.com.cn/currmedsci/EN/10.1007/s11596-023-2760-3
请登录并选择要私信的好友
300
Advances in Studies of Chiglitazar Sodium, a Novel PPAR Pan-Agonist, for the Treatment of Type 2 Diabetes Mellitus https://journal.hep.com.cn/currmedsci/EN/10.1007/s11596-023-2760-3
赞一下这个内容
公开
分享
获取分享按钮
正在发布微博，请稍候